<p>Mustang Bio Inc. held its 2025 annual meeting of stockholders on December 22, 2025. At the meeting, stockholders approved the election of seven directors, ratified the appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2025, approved an amendment to the Employee Stock Purchase Plan to increase the number of shares issuable and the number of shares subject to a purchase right, and approved an amendment to the 2016 Incentive Plan to increase the number of shares issuable. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mustang Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124189), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

MBIO

<p>Mustang Bio Inc. held its 2025 annual shareholder meeting on December 22, 2025. Shareholders approved the election of seven directors, ratified KPMG LLP as the accounting firm, and amended the Employee Stock Purchase Plan and 2016 Incentive Plan to increase shares issuable. This summary is AI-generated and not financial advice.</p>

Mustang Bio Inc. held annual shareholder meeting